Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Schwarzschild Radius and Event Horizon01:21

Schwarzschild Radius and Event Horizon

2.8K
No object with a finite mass can travel faster than the speed of light in a vacuum. This fact has an interesting consequence in the domain of extremely high gravitational fields.
The minimum speed required to launch a projectile from the surface of an object to which it is gravitationally bound so that it eventually escapes the object’s gravitational field is called the escape velocity. The escape velocity is independent of the mass of the object. Merging the idea of escape...
2.8K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

968
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
968
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

1.7K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Urological problems related to coloproctology. Part 2].

Urologiia (Moscow, Russia : 1999)·2022
Same author

[Urological problems related to coloproctology. Part 1].

Urologiia (Moscow, Russia : 1999)·2022
Same author

[Evaluation of the influence of systemic enzyme therapy on immune reactions in genitourinary chlamydia infection].

Urologiia (Moscow, Russia : 1999)·2020
Same author

[25-year trends of incidence and mortality from liver cancer and viral hepatitis in Novosibirsk].

Voprosy onkologii·2018
Same author

DIAGNOSTIC SIGNIFICANCE OF SKIN "SIGNS" IN CHRONIC DIFFUSE LIVER DISFASES.

Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology·2018
Same author

[The role of mycoplasma infection (M. hominis and U. urealyticum) in inflammatory diseases of the genitourinary system the debate continues].

Urologiia (Moscow, Russia : 1999)·2017
Same journal

New Data on Molecular Targets of Tamoxifen Besides Estrogen Receptors, Their Clinical Significancy.

Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]·2018
Same journal

Plant Extracts in Development of Medicinal Products of Various Therapeutic Value.

Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]·2018
Same journal

Macrolide Resistance and Its Molecular Genetic Mechanisms in Streptococcus pyogenes Isolated from Children.

Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]·2018
Same journal

Experimental Substantiation of Taurine Use in Prophylaxis of Isoniazid-Induced Neurotoxic Reactions.

Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]·2018
Same journal

Biologically Active Substances from Marine Hydrobionts with Antibacterial Activity in Composition of New Wound Dressings.

Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]·2018
Same journal

Electrooptical Assay for Record of Antibiotic Action on Microbial Cells.

Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]·2018
See all related articles

Related Experiment Video

Updated: Feb 9, 2026

Imaging of In Situ Interferon Gamma Production in the Mouse Spleen following Listeria monocytogenes Infection
09:11

Imaging of In Situ Interferon Gamma Production in the Mouse Spleen following Listeria monocytogenes Infection

Published on: July 16, 2019

9.7K

Interferon-Gamma: Treatment Horizons.

A A Khryanin, O V Reshetinikov

    Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]
    |June 7, 2018
    PubMed
    Summary
    This summary is machine-generated.

    This review explores the interferon system, focusing on interferon-gamma

    More Related Videos

    Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination
    08:13

    Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

    Published on: January 20, 2019

    22.5K
    Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses
    10:10

    Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses

    Published on: November 16, 2016

    14.3K

    Related Experiment Videos

    Last Updated: Feb 9, 2026

    Imaging of In Situ Interferon Gamma Production in the Mouse Spleen following Listeria monocytogenes Infection
    09:11

    Imaging of In Situ Interferon Gamma Production in the Mouse Spleen following Listeria monocytogenes Infection

    Published on: July 16, 2019

    9.7K
    Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination
    08:13

    Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

    Published on: January 20, 2019

    22.5K
    Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses
    10:10

    Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses

    Published on: November 16, 2016

    14.3K

    Area of Science:

    • Immunology and Molecular Biology
    • Virology
    • Oncology

    Background:

    • Interferons are crucial signaling proteins in the immune system.
    • Understanding interferon-gamma's (IFN-γ) immunomodulatory functions is key.
    • The review synthesizes current literature on interferon biology.

    Purpose of the Study:

    • To present updated data on the interferon system.
    • To highlight the role of interferon-gamma in immune responses.
    • To evaluate the therapeutic potential of Ingaron.

    Main Methods:

    • Literature review of modern scientific data.
    • Analysis of studies on interferon-producing cells and target cells.
    • Examination of clinical data on Ingaron efficacy.

    Main Results:

    • Interferon-gamma exhibits significant immunomodulatory effects.
    • Ingaron demonstrates high efficacy in treating viral and infectious diseases.
    • Ingaron shows promise in the management of oncologic conditions.

    Conclusions:

    • The interferon system is complex, involving diverse cell types.
    • Interferon-gamma plays a vital role in immune regulation.
    • Ingaron is an effective therapeutic agent for multiple disease categories.